DEF: Integrated Wellness Seeks SPAC Extension to September 2026

Integrated Wellness Acquisition Corp. is seeking shareholder approval to extend its business combination deadline from March 16, 2026, to September 16, 2026, to finalize its merger with Btab Ecommerce Group.

Summary

• Integrated Wellness Acquisition Corp. (the Company), a Cayman Islands-incorporated blank check company (SPAC), is holding an Extraordinary General Meeting on March 12, 2026.
• Shareholders will vote on two special resolutions (M&A Amendment Proposals) which are conditioned on each other: (1) to extend the deadline for completing a business combination from March 16, 2026, to September 16, 2026, and (2) to permit the Board, in its sole discretion, to elect to wind up operations on or before September 16, 2026 (including prior to March 16, 2026).
• A third proposal is for an Adjournment, if necessary, to permit further solicitation and vote of proxies.
• The Company's shareholders previously approved a business combination with Btab Ecommerce Group, Inc. (Btab) at a separate meeting on December 8, 2025.
• The Board believes there may not be sufficient time to complete the Btab Business Combination by the current March 16, 2026, deadline and that the extension is in the best interests of shareholders to allow participation in the future investment.
• Public shareholders have the right to redeem their shares for cash, which was approximately $12.91 per share as of December 31, 2025. This compares to a closing market price of $12.21 per Class A ordinary share on February 20, 2026.
• If the M&A Amendment Proposals are not approved and the business combination is not completed by March 16, 2026, the Company will liquidate, and its warrants will expire worthless.
• The Trust Account held approximately $15.3 million as of December 31, 2025.
• As of February 23, 2026, there are 2,950,891 Ordinary Shares issued and outstanding, consisting of 75,891 Class A and 2,875,000 Class B shares.
• The Sponsor (Suntone Investment Pty Ltd) and the Company's directors and officers own 2,012,500 Class B Ordinary Shares (representing approximately 68.2% of total outstanding shares) and 4,795,000 Private Placement Warrants, all of which would become worthless upon liquidation.
• The Sponsor and its affiliates have made outstanding loans and advances to the Company totaling approximately $5.99 million, which may not be repaid if a business combination is not completed.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development, reflecting continued operational delays and a struggle to finalize a business combination, which has led to substantial prior redemptions and a market price below the trust value.

Positives

• Shareholders previously approved the Btab Business Combination on December 8, 2025, indicating a path forward for the company.
• The proposed extension provides an additional six months (until September 16, 2026) to complete the approved business combination, potentially preserving shareholder value and allowing for the transaction to close.
• The Board retains flexibility to liquidate the Trust Account and redeem all public shares earlier than the Extended Date if a business combination becomes unfeasible, offering a degree of protection for public shareholders.
• Public shareholders have redemption rights at an estimated price of $12.91 per share (as of December 31, 2025), which is higher than the market closing price of $12.21 per Class A ordinary share on February 20, 2026, presenting an arbitrage opportunity.

Negatives

• The company is seeking its fifth extension since its IPO, indicating persistent difficulties and delays in completing a business combination.
• Previous extension votes resulted in significant redemptions: 6,108,728 Class A shares for approximately $64.98 million in June 2023, and 1,136,155 public shares for approximately $12.6 million in December 2023, substantially reducing the Trust Account balance.
• The Sponsor and management have a strong economic incentive to complete a business combination, even if less favorable, as their 2,012,500 Class B shares (market value $24.6 million) and 4,795,000 Private Placement Warrants (market value $196,595) would be worthless upon liquidation.
• Outstanding loans of approximately $5.99 million from the Sponsor and its affiliates may not be repaid if a business combination is not completed, creating a potential loss for related parties.
• The company cannot assure shareholders that they will be able to sell their public shares in the open market, even if the market price per share is higher than the redemption price, due to potential liquidity issues.
• There is a potential for a 1% U.S. federal excise tax on redemptions if the company domesticates to Delaware and redemptions occur after or in connection with the initial business combination.

Risks

• There are no assurances that the proposed extension will enable the company to complete a business combination by the Extended Date.
• Significant redemptions by public shareholders could leave the company with insufficient cash to consummate an initial business combination on commercially acceptable terms, or at all.
• The company's ability to consummate any business combination is dependent on a variety of factors, many of which are beyond its control.
• Foreign ownership by the Sponsor and its management may subject certain acquisitions or an initial business combination with U.S. targets to review or approval by regulatory authorities (e.g., CFIUS), potentially delaying or preventing the transaction.
• Changes in laws or regulations, or a failure to comply with them, may adversely affect the company's business, including its ability to negotiate and complete its initial business combination.
• The Sponsor's agreement to indemnify the company for certain third-party claims against the Trust Account may not be satisfiable, as the Sponsor's only assets are believed to be company securities.
• If the company liquidates, its warrants will expire worthless, resulting in a complete loss for warrant holders.
• The price of the company's shares may be volatile, and there is no assurance that shareholders will be able to dispose of their shares at favorable prices, or at all.

Future Outlook

The company intends to complete the Btab Business Combination as soon as possible, and in any event, on or before the Extended Date of September 16, 2026, if the M&A Amendment Proposals are approved and implemented. If the business combination is completed prior to the March 12, 2026 meeting, the meeting will be canceled, and the extension will not be implemented.

Management Comments

• The Board believes that there may not be sufficient time before the Termination Date to complete the Business Combination.
• The Board believes that in order to be able to consummate the Business Combination, the Company will need to obtain approval for the Extension.
• Without the Extension, the Board believes that there is significant risk that the Company might not, despite its best efforts, be able to complete the Business Combination on or before the Termination Date.
• The Board has determined that it is in the best interests of the Company's shareholders to extend the date by which the Company has to consummate the Business Combination to the Extended Date in order that the Company's shareholders have the opportunity to participate in its future investment, as well as to provide additional flexibility to wind up our operations prior to the end of the Extension Period.
• The Board unanimously recommends that shareholders vote FOR each of the Extension Amendment Proposal, the Liquidation Amendment Proposal and the Adjournment Proposal.

Industry Context

StockSavvy.ai notes that this filing is typical for a Special Purpose Acquisition Company (SPAC) nearing its dissolution deadline without having completed its initial business combination. The repeated requests for extensions and significant prior redemptions highlight the inherent challenges and risks associated with SPACs in identifying and closing suitable merger targets within their mandated timelines. The proposed extension, coupled with the Board's discretion to liquidate, reflects a common strategy to balance the pursuit of a deal with the need to protect remaining shareholder capital. The redemption price being higher than the market price indicates a potential arbitrage opportunity for public shareholders, a common feature in SPACs facing liquidation or extension votes.

Comparison to Industry Standards

• The redemption price of $12.91 per share compared to a market price of $12.21 offers a 5.7% premium, which is a notable arbitrage opportunity for public shareholders, often seen in SPACs facing extension votes or liquidation. This is a common scenario where the trust value exceeds the market trading price due to market skepticism about the SPAC's ability to close a favorable deal.
• The repeated extensions (June 2023, December 2023, December 2024, December 2025, and now seeking to September 2026) are indicative of a SPAC struggling to find or close a suitable business combination, a trend observed across the SPAC market, particularly for those that launched in the 2020-2021 boom. Many SPACs from that era have faced similar challenges, leading to multiple extensions or eventual liquidation.
• The significant redemptions in previous extension votes (e.g., $64.98 million in June 2023 and $12.6 million in December 2023) are consistent with industry trends where public shareholders opt for redemption when a SPAC seeks extensions, especially if the market perceives the target or the deal terms as less attractive, or if the trust value offers a safer return.
• The Btab Business Combination, an e-commerce group, aligns with the broader trend of SPACs targeting growth sectors, though the prolonged timeline suggests complexities in closing the deal, a common hurdle for SPACs attempting to merge with private companies.

Management Changes

Corporate Governance

Related Party Transactions

• The Sponsor and its affiliates have made outstanding loans and advances to the Company in the aggregate amount of approximately $5.99 million.
• The Sponsor and the Company's directors and officers own 2,012,500 Class B Ordinary Shares (purchased for $25,000) and 4,795,000 Private Placement Warrants, which would become worthless if the company liquidates.
• The Sponsor and its affiliates are entitled to reimbursement of out-of-pocket expenses incurred on the Company's behalf, but these will not be reimbursed from the Trust Account if a business combination is not completed.
• The Sponsor may enter into arrangements with a limited number of shareholders to agree not to redeem public shares, potentially offering Class B ordinary shares, membership interests in the Sponsor, or other consideration.

Stakeholder Impact

• Shareholders (Public): Opportunity to redeem shares at a premium to market price ($12.91 vs $12.21). Risk of losing investment if no business combination is completed and company liquidates (warrants expire worthless). Opportunity to participate in future investment if business combination closes.
• Shareholders (Sponsor/Insiders): Significant financial incentive to complete a business combination to avoid their Class B shares and Private Placement Warrants becoming worthless. Risk of not recouping $5.99 million in loans if liquidation occurs.
• Btab Ecommerce Group, Inc.: The proposed extension is crucial for the completion of the previously approved business combination, impacting its ability to go public.
• Creditors: The company has obligations under Cayman Islands law to provide for claims of creditors in case of liquidation.

Next Steps

• Hold an Extraordinary General Meeting on March 12, 2026, to vote on the Extension Amendment Proposal, the Liquidation Amendment Proposal, and the Adjournment Proposal.
• If the M&A Amendment Proposals are approved, file the resulting amendments to the M&A with the Registrar of Companies of the Cayman Islands within fifteen days of passing the special resolutions.
• Continue efforts to consummate the Btab Business Combination as soon as possible, and in any event, on or before the Extended Date of September 16, 2026.
• If the Business Combination is completed prior to the March 12, 2026 meeting, the meeting will be canceled, and the extension will not be implemented.
• If the M&A Amendment Proposals are not approved and the Business Combination is not completed on or before March 16, 2026, the company will cease operations, redeem public shares, and liquidate.

Key Dates

Recommendation

The filing presents a complex situation for Integrated Wellness Acquisition Corp. While the proposed extension offers a lifeline to complete the Btab Business Combination, the history of multiple extensions and significant prior redemptions indicates ongoing challenges and market skepticism. The current redemption price offers an arbitrage opportunity above the market price, suggesting a 'sell' for those seeking a guaranteed return. However, for investors who believe in the potential of the Btab merger, holding through the extension vote might be considered, given the prior shareholder approval of the business combination itself. The Board's added flexibility to liquidate earlier also provides a degree of downside protection. Given the uncertainty and the potential for further redemptions, a 'hold' recommendation balances the arbitrage opportunity with the speculative upside of the merger, while acknowledging the significant risks.

Keywords

SPAC, Integrated Wellness Acquisition Corp, Btab Ecommerce Group, Business Combination, Extension, Liquidation, Proxy Statement, Shareholder Meeting, Redemption Rights, Trust Account, Corporate Governance, Merger, SEC Filing, DEF 14A